Autres langues

25/08 Compumedics Limited Reports Earnings Results for the Full Year Ended June 30, 2026
25/08 Compumedics Fiscal 2026 EBITDA, Revenue Up
06/07 Compumedics Limited Revises Earnings Guidance for the Fiscal Year 2026
06/07 Compumedics Limited Announces Resignation of Christopher R. Barys as Non-Executive Director, Effective 30 June 2026
06/07 Compumedics Limited Provides Earnings Guidance for the Fiscal Year 2027
09/06 Compumedics Limited Announces Appointment of Mike Stone as Chief Commercial Officer for Its US Operations
21/04 Compumedics Sees Fiscal Year 2026 EBITDA of Up to AU$7 Million
21/04 Compumedics updates FY26 EBITDA guidance A$5.5 million-A$7 million
21/04 Compumedics Limited Updates Earnings Guidance for the Fiscal Year 2026
24/02 Compumedics Limited Reports Earnings Results for the Half Year Ended December 31, 2025
29/01 Compumedics Secures AU$4.2 Million Order for Orion LifeSpan MEG System
29/01 Compumedics secures new A$4.2 million MEG sales order
22/01 Compumedics posts revenue of A$30.8 million for H1FY26
21/01 Compumedics Limited Provides Earnings Guidance for the Fiscal Year 2026
10/11 Compumedics secures new A$4.9 million MEG sales order
30/10/25 Compumedics Limited Elects Mr. Christopher Barys as Director
15/10/25 Compumedics Raises Over AU$2 Million Via Placement
15/10/25 Compumedics raises a$2.15 million via placement at a$0.285 per share
12/10/25 Compumedics seeks trading halt pending capital raising announcement
22/09/25 Compumedics Ltd expects FY26 revenue to exceed A$70 mln with Ebitda of A$9 mln
22/09/25 Compumedics Limited Provides Earnings Guidance for the Fiscal Year 2026
22/09/25 Compumedics Limited Appoints Christopher R. Barys as Non-Executive Director, Effective 22 September 2025
04/09/25 Compumedics says U.S. FDA granted 510(k) clearance for Somfit D device (K252383)
04/09/25 Compumedics' Sleep Testing Device Receives US FDA Clearance
27/08/25 Compumedics Limited Reports Earnings Results for the Full Year Ended June 30, 2025
Aucun résultat pour cette recherche